AstraZeneca Plc (AZN)

43.87
0.26 0.59
NYSE : Health Technology
Prev Close 44.13
Open 44.18
Day Low/High 43.67 / 44.20
52 Wk Low/High 35.30 / 46.22
Volume 1.65M
Avg Volume 3.45M
Exchange NYSE
Shares Outstanding 2.62B
Market Cap 114.91B
EPS 0.80
P/E Ratio 19.79
Div & Yield 1.37 (3.10%)

Shorting AZN

I doubt this story. A London Sunday Times article suggests that Pfizer (PFE) considered acquiring AstraZeneca (AZN), but the talks stalled and will not resume. I am doubtful of this story and I have shorted AZN, +$6 in premarket trading as the compa...

Array CEO: Partnerships Smart While Cancer Drug Develops

Array CEO: Partnerships Smart While Cancer Drug Develops

Array is partnering with AstraZeneca and Novartis on a number of cancer drugs with trials soon getting underway that could transform the company by year end.

Analyst Says Actavis' $25 Billion Purchase of Forest Labs is Smart

Analyst Says Actavis' $25 Billion Purchase of Forest Labs is Smart

James Molloy, Managing Director at Janney Montgomery Scott explains why Actavis buying Forest Labs is a smart for Actavis and weighs in on speculation over whether or not Forest Labs is likely to receive a better offer.

European Stocks Rally on Fed Guidance; Drugmakers Strike Deals

European Stocks Rally on Fed Guidance; Drugmakers Strike Deals

The U.K.'s AstraZeneca and Germany's Bayer spend up to a combined $7.2 billion shoring up their portfolios. Laura Board reports from London.

Keep Calm and Carry EWU

The UK is the next geographic hotspot. Play it with this ETF.

S&P Lifts U.S. Credit Outlook

S&P Lifts U.S. Credit Outlook

Credit rating agency Standard & Poor's upgrades its credit outlook for the U.S. government to Stable from Negative.

Stocks Follow Japan's Lead Upward

Stocks Follow Japan's Lead Upward

Merger Monday begins with AstraZeneca buying Pearl, while Apple could announce iRadio and Google may purchase Waze as futures look up.

Millions for Fish Oil

Millions for Fish Oil

Stocks are up as AstraZeneca pays millions for Omthera, while Valeant buys Bausch & Lomb and Tiffany's earnings shine.

The Biotech Revaluation Is On

These four names in particular have made some stunning moves.

AstraZeneca estimates cut at Leerink

Trending Now: HPQ Announces 10% Increase in Quarterly Dividend

Trending Now: HPQ Announces 10% Increase in Quarterly Dividend

Hewlett-Packard announces a 10% increase in its quarterly dividend. Brittany Umar has details on that as well as a look at the day's other most searched trends on the Web.

IPOs: LifeLock, Luxfer, Regulus

IPOs: LifeLock, Luxfer, Regulus

LifeLock looks to be the best offering for the IPOs planned on Wednesday according to IPO Desltop President Francis Gaskins.

Three U.K. Gold Medalists

These companies are performing like champions, despite a weak British economy.

Trading Abbott for Bristol Myers

Trading Abbott for Bristol Myers

Stephanie Link, director of research at TheStreet, eliminated her position in Abbott to build a position in Bristol Meyers.

Apple Pays Proview $60 Million in iPad Dispute: Hot Trends

Apple Pays Proview $60 Million in iPad Dispute: Hot Trends

A look at some of the day's most searched topics on the Web, includingApple as the company shells out $60 million to settle its iPad namingdispute with Proview Technology.

The Next Big Thing in Biotech: M&A

The Next Big Thing in Biotech: M&A

Senior columnist Adam Feuerstein says M&A is the next big thing in biotech.

AstraZeneca Buys Ardea Biosciences for $1.26 Billion: Hot Trends

AstraZeneca Buys Ardea Biosciences for $1.26 Billion: Hot Trends

A look at the day's most searched trends on the Web, including AstraZeneca's purchase of Ardea Biosciences for $1.26 billion.

The Day Ahead: Anticipating Economic Data

European headlines worried traders ahead of the open, as they await a raft of economic and retail reports.

Adding New Names to the Wish List

Net-cash stocks can be the Christmas gifts that keep on giving.

Finding an Antidote for Health Care

The sector is in the doldrums, yet the prospects for these three names are quite strong.

Portfolio Protection Is Paramount

Forget about hitting home runs and focus on avoiding strikeouts.